| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65219-826-26 | 65219-826 | HUMAN PRESCRIPTION DRUG | Otulfi | ustekinumab-aauz | INJECTION, SOLUTION | SUBCUTANEOUS | 20240222 | N/A | BLA | BLA761379 | Fresenius Kabi USA, LLC | USTEKINUMAB | 90 mg/mL | 1 SYRINGE in 1 CARTON (65219-826-26) / 1 mL in 1 SYRINGE |
| 65219-828-05 | 65219-828 | HUMAN PRESCRIPTION DRUG | Otulfi | ustekinumab-aauz | SOLUTION | INTRAVENOUS | 20240222 | N/A | BLA | BLA761379 | Fresenius Kabi USA, LLC | USTEKINUMAB | 130 mg/26mL | 1 VIAL in 1 CARTON (65219-828-05) / 26 mL in 1 VIAL |
| 65219-824-01 | 65219-824 | HUMAN PRESCRIPTION DRUG | Otulfi | ustekinumab-aauz | INJECTION, SOLUTION | SUBCUTANEOUS | 20240222 | N/A | BLA | BLA761379 | Fresenius Kabi USA, LLC | USTEKINUMAB | 45 mg/.5mL | 1 SYRINGE in 1 CARTON (65219-824-01) / .5 mL in 1 SYRINGE |
| 65219-866-26 | 65219-866 | HUMAN PRESCRIPTION DRUG | USTEKINUMAB-AAUZ | ustekinumab-aauz | INJECTION, SOLUTION | SUBCUTANEOUS | 20251115 | N/A | BLA | BLA761379 | Fresenius Kabi USA, LLC | USTEKINUMAB | 90 mg/mL | 1 SYRINGE in 1 CARTON (65219-866-26) / 1 mL in 1 SYRINGE |
| 65219-822-05 | 65219-822 | HUMAN PRESCRIPTION DRUG | Otulfi | ustekinumab-aauz | INJECTION, SOLUTION | SUBCUTANEOUS | 20250929 | N/A | BLA | BLA761379 | Fresenius Kabi USA, LLC | USTEKINUMAB | 45 mg/.5mL | 1 VIAL in 1 CARTON (65219-822-05) / .5 mL in 1 VIAL |
| 65219-862-01 | 65219-862 | HUMAN PRESCRIPTION DRUG | USTEKINUMAB-AAUZ | ustekinumab-aauz | INJECTION, SOLUTION | SUBCUTANEOUS | 20251115 | N/A | BLA | BLA761379 | Fresenius Kabi USA, LLC | USTEKINUMAB | 45 mg/.5mL | 1 SYRINGE in 1 CARTON (65219-862-01) / .5 mL in 1 SYRINGE |